LAG3, often expresses on the lymphocytes, including CD4+ T cells, NK cells, CD8+ T cells, and Treg cells, impeding the tumor immune microenvironment through accelerating T cell exhaustion and blocking T cell proliferation. Here, LAG3 is linked to neoplasm.